FLGT
Fulgent Genetics Inc
NASDAQ: FLGT · HEALTHCARE · DIAGNOSTICS & RESEARCH
$15.19
+2.64% today
Updated 2026-04-30
Market cap
$470.46M
P/E ratio
—
P/S ratio
1.46x
EPS (TTM)
$-1.97
Dividend yield
—
52W range
$13 – $31
Volume
0.7M
Fulgent Genetics Inc (FLGT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-4.40M | $-969000.00 | $4.41M | $1.33M | $-675000.00 | $5.52M | $140.63M | $538.58M | $253.52M | $27.00M | $21.06M | $-101.64M |
| Capital expenditures | $731000.00 | $2.10M | $3.79M | $5.36M | $2.83M | $1.18M | $36.51M | $23.84M | $18.77M | $22.21M | $40.31M | $22.57M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $8.16M | $4.65M | $2.12M | $2.30M | $3.21M | $8.16M | $15.88M | $32.64M | $42.92M | $44.48M | $39.58M |
| Free cash flow | $-5.13M | $-3.07M | $617000.00 | $-4.03M | $-3.51M | $4.33M | $104.12M | $514.73M | $234.75M | $4.80M | $-19.25M | $-124.21M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | $4.59M | $4.59M | $4.59M | $0.00 | — | — | $15.02M | $4.16M | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $7.40M | $-1.41M | $246000.00 | $5.25M | $75.44M | $77.43M | — | — | — | — |